Company profile
K Pharma,Inc.
Industry position
Pharmaceutical
Latest half-year results
H1 FY2026
Operating income was -¥471.15 million, down 7.7% year over year. Net income was -¥492.7 million, down 10.8% year over year.
Half-year trend
Half-year financial trend
H1 values are cumulative year-to-date.
H2 values are calculated when comparable.
Standalone · Japanese GAAP · Cumulative YTD
Half-year financial data
Annual key financial indicators
FY2025
Operating income was -¥916.06 million, down 9.5% year over year. Net income was -¥993.23 million, down 17.3% year over year. ROE was -78.5%; equity ratio was 43.1%; free cash flow was -¥972.69 million.
Industry position details
Pharmaceutical
Annual data for the same fiscal year and industry
FY2025 Comparison sample 32
ROE Bottom 85%
Equity ratio Bottom 88%
Annual financial data
| Fiscal year | Scope | Accounting standard | Revenue | Operating income | Ordinary income | Profit before tax | Net income | Profit attributable to owners of parent | Comprehensive income | Total assets | Total liabilities | Net assets | Shareholders' equity | Equity | Equity attributable to owners of parent | Equity for ratio | Operating cash flow | Investing cash flow | Financing cash flow | Free cash flow | Cash and cash equivalents | Basic EPS | P/E | Share price | Market cap | Book value per share | Dividend per share | Shares issued | Equity ratio | Official equity ratio | ROE | ROA | Operating margin | Ordinary income margin | Net margin | Operating cash flow margin | Free cash flow margin | Dividend payout ratio | Revenue YoY | Operating income YoY | Ordinary income YoY | Profit before tax YoY | Net income YoY | Total assets YoY | Equity YoY | Operating cash flow YoY | Investing cash flow YoY | Financing cash flow YoY | Free cash flow YoY | Cash and cash equivalents YoY | EPS YoY | Dividend per share YoY | Shares issued YoY | Employees YoY | Average salary YoY | Employees | Average salary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Standalone | Japanese GAAP | -916056000 | -920527000 | -993227000 | 2939220000 | 1673785000 | 1265435000 | 1265435000 | 1265435000 | -918005000 | -54683000 | 1496325000 | -972688000 | 2791835000 | -85.59 | 109.0 | 11609600 | 0.4305342914 | 0.431 | -0.784889781 | -0.3379219657 | -0.0953074445 | -0.1007888855 | -0.1733961049 | 0.2490985193 | -0.4396544853 | 0.0668015968 | -2.7738440304 | 0.0255667901 | 0.230860357 | -0.1734302166 | 0.0004308636 | 0.1764705882 | 0.1346729905 | 20 | 9091000 | ||||||||||||||||||||
| FY2024 | Standalone | Japanese GAAP | -836346000 | -836243000 | -846455000 | 2353073000 | 94760000 | 2258312000 | 2258312000 | 2258312000 | -983719000 | -14490000 | -998209000 | 2268198000 | -72.94 | 194.6 | 11604600 | 0.9597288312 | 0.96 | -0.3748175629 | -0.3597232215 | -3.2847425401 | -3.4296393789 | -4.251469289 | -0.2899388696 | -0.2726309985 | -3.1647554602 | -0.3055230201 | -3.2516364932 | -0.3055986882 | -3.8693941778 | 0.0 | 0.1333333333 | -0.0211362248 | 17 | 8012000 | |||||||||||||||||||||
| FY2023 | Standalone | Japanese GAAP | 1000000000 | 366057000 | 344184000 | 260330000 | 3313902000 | 209134000 | 3104768000 | 3104768000 | 3104768000 | 454425000 | -11099000 | 1486235000 | 443326000 | 3266408000 | 25.42 | 28.3 | 719.386 | 8348186775.600 | 267.55 | 11604600 | 0.9368919177 | 0.937 | 0.083848455 | 0.0785569398 | 0.366057 | 0.344184 | 0.26033 | 0.454425 | 0.443326 | 15 | 8185000 |
Source filings
Select a document type to load the filings list.
Source data: Financial Services Agency EDINET / Data organization, aggregation, and metric calculations: bestforever.jp